An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta at Different Time Intervals During Controlled Ovarian Stimulation.
Clinical trial NCT06511791 · TERMINATED
Trial details
- NCT number
- NCT06511791
- Sponsor
- Ferring Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-15
- Primary completion
- 2025-10-16
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.